C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
11/2004
11/11/2004	US20040224906 Process for extracting polyphenolic antioxidants from purine-containing plants
11/10/2004	EP1475382A1 Compounds as semaphorin inhibitors
11/10/2004	EP1474412A2 Production of delta-9 tetrahydrocannabinol
11/10/2004	EP1451171A4 Method for preparing chiral amines
11/10/2004	EP1363896B1 Synthesis of beta-lapachone and its intermediates
11/10/2004	EP1242361B1 Process of preparing tolterodine and analogues there of as well as intermediates prepared in the process
11/10/2004	EP1140181B1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
11/10/2004	EP1054008B1 Process for the preparation of isoflavone compounds
11/10/2004	EP1027043B1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
11/10/2004	CN1545700A Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
11/10/2004	CN1544430A Isoflavone compound preparing method
11/10/2004	CN1544429A Bee glue flavone extract preparation method, pharmaceutical preparation and its new medical uses
11/10/2004	CN1544428A Flavonoid compound extracted from Chinese traditional medicine water banyan
11/10/2004	CN1544427A Luteolin semi-synthesis method
11/10/2004	CN1544426A Extracting and separating method of langdu root chromone from Stellera chamaejasme L. and its uses
11/10/2004	CN1544425A Daphnetin derivative
11/10/2004	CN1174975C Benzopyrans compound and their use as therapeutic agent
11/09/2004	US6815551 Processes for concentrating tocopherols and/or sterols
11/09/2004	US6814958 Extract selected from the group of grape seed extract, a green tea extract, a blueberry extract and a silymarin extract; and at least one member selected from vitamin c and and vitamin e for treating periodontosis
11/04/2004	WO2004094413A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004	WO2004094401A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
11/04/2004	WO2004094400A2 Substituted benzopyrans as selective estrogen receptor-beta agonists
11/04/2004	WO2004094384A2 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease
11/04/2004	WO2004093856A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	WO2004009035A3 Compositions and products containing enantiomeric equol, and methods for their making
11/04/2004	WO2004003550A3 Individualization of therapy with anticoagulants
11/04/2004	US20040220392 Compositions for, and methods of, treating atherosclerosis
11/04/2004	US20040220258 use of 3-(4-Hydroxy-2-oxo-2H-chromen-3-yl)-3-phenyl-propionic acid, 3-(4-Hydroxy-2-oxo-2H-chromen-3-yl)-3-phenyl-propionic acid methyl ester, for example, as anticoagulants
11/04/2004	US20040220257 modulating the activity of the mitochrondrial permeability transition pore complex comprising exposing said complex to compound such as Spiro [Cyclopentane-1,5'-[5H]Dibenzo [a,d]Cyclohepten]-2-one, 10', 11'-dihydro-3-methylene-
11/04/2004	US20040219386 4,4'-bis-(spiro 9-fluorene-9'-acridin-10-yl)biphenyl for example, having visible light emissive, hole-transport, electron transport or bipolar-transport properties; use as emissive layer, charge transport layer, or as host material for such layers
11/04/2004	CA2523232A1 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer's disease
11/04/2004	CA2522805A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004	CA2522667A1 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	CA2518819A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
11/03/2004	EP1472514A2 Method of preparing delta-9 tetrahydrocannabinol
11/03/2004	EP1301504B1 Bifunctional agents possessing antioxidant and antiarrhythmic activity
11/03/2004	CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004	CN1541994A Method for preparing Duosairuilong compound and application thereof
11/03/2004	CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
11/03/2004	CN1173967C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
11/03/2004	CN1173966C Method for preparing DL-alpha-tocopherol with high yield and high purity
11/03/2004	CN1173965C Process for separating compound anisodus luridus from plant Artemisia annua
11/03/2004	CN1173953C Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
11/03/2004	CN1173724C Systemic separation process and preparation of gingkgo leaf extract
11/02/2004	US6812353 Intermediates for central nervous system medications; primary amine functionality
11/02/2004	US6812331 Aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments
11/02/2004	US6812246 Trifluoroaminoflavone compounds which are substituted with amine-containing groups at the 5- and/or 4'- flavone ring position; water solubility and solubility in organic solvents; antitumor and anticarciogenic agents
11/02/2004	US6812225 Pyschological disorders; antidepressants
10/2004
10/28/2004	WO2004092154A1 Compositions useful as inhibitors of protein kinases
10/28/2004	WO2004092153A1 Diamine derivative, production process, and antioxidizing drug
10/28/2004	WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	WO2004092101A2 Olivetol-cyclodextrin complexes and regio-selective process for preparing delta 9-tetrahydrocannabinol
10/28/2004	WO2004091604A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004	WO2004073612A3 Estrogen receptor modulators
10/28/2004	WO2003080593A8 Hydrophilic polymers-flavonoids conjugates and pharmaceutical compositions comprising them
10/28/2004	US20040215024 naphthopyrans having an oxygen-containing heterocyclic group F annelated on the i, j, or k side of the naphthopyran ring; have interesting photochromic properties; part of polymer or in polymer matrix; ophthalmic lenses
10/28/2004	US20040215003 Method for purifying and separating soy isoflavones
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214199 comprising protected hydrazino, oxyamino and carbonyl-based groups biochemical immobilization; solid phase synthesis
10/28/2004	CA2527170A1 Therapeutic compounds
10/28/2004	CA2522595A1 Compositions useful as inhibitors of protein kinases
10/28/2004	CA2522118A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004	CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	CA2521920A1 Olivetol-cyclodextrin complexes and regio-selective process for preparing delta 9-tetrahydrocannabinol
10/27/2004	EP1471065A1 Novel 1,2,4-triazole compound
10/27/2004	EP1471064A1 Coumarin derivatives, process for their production and use thereof
10/27/2004	EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/27/2004	EP0960108B1 Matrix metalloproteinase inhibitors
10/27/2004	CN1541262A Hops extracts, method for prodn. and use
10/27/2004	CN1541219A Tricyclic imidazopyridines
10/27/2004	CN1539985A Method for extracting isoflavone from soybean
10/27/2004	CN1539825A Compounds useful to treat retroviral infections
10/27/2004	CN1172926C Astragalus calycosin and its glycoside with the function of resisting myocardial ischemia
10/27/2004	CN1172917C Steroid receptor modulator compounds and methods
10/26/2004	US6809225 Method for producing 3,3-diarylpropylamines
10/26/2004	US6809214 Shortened synthesis of 3,3-diarylpropylamine derivatives
10/26/2004	US6809176 Compounds for use in treatment of cancer
10/26/2004	US6809114 4-aminobenzopyran derivatives
10/26/2004	US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
10/26/2004	US6809088 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
10/26/2004	CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
10/21/2004	WO2004089926A2 Genipin derivatives and uses thereof
10/21/2004	WO2004089925A1 Pi-3 kinase inhibitor prodrugs
10/21/2004	WO2004047674A3 Oxyge-containing heterocyclic fused naphthopyrans
10/21/2004	US20040210076 Carene epoxide intermediate that has been used as a precursor to tetrahydrocannabinoids
10/21/2004	US20040209942 treating cancer and apoptosis-associated disorders using cell cycle checkpoint activation modulators; also screening for the modulators
10/21/2004	US20040209936 Compounds that modulate PPAR activity and methods of preparation
10/21/2004	US20040209925 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide
10/21/2004	US20040209825 Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto
10/21/2004	CA2518916A1 Pi-3 kinase inhibitor prodrugs
10/20/2004	EP1468995A1 MPTP affinity labels
10/20/2004	EP1468990A1 Piperazine derivative
10/20/2004	EP1468064A1 Fragrance compound
10/20/2004	EP1467998A1 Tetracyclic heterocompounds as estrogen receptor modulators
10/20/2004	EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones
10/20/2004	CN1537865A Method of extracting lactoalbumin, nucleic acid oligosaccharide, isoflavone, saponin from yellow waste water generated by producing soybean
10/20/2004	CN1171897C Macroporous adsorbing resin process of extracting general flavone from haw leaf
10/19/2004	US6806288 Cyclooxygenase-2 mediated disorders; reduces inflammation; fewer side effects
10/19/2004	US6805873 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment
10/14/2004	WO2004087687A1 Chromene derivatives as anti-inflammatory agents

1 ... 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 ... 242